EODData

MEMBERSHIP REGISTER LOG IN

FRA, I9DN: Arbutus Biopharma Corp

30 Jul 2026
LAST:

3.680

CHANGE:
 0.00		OPEN:
3.680		HIGH:
3.680		ASK:
0.000		VOLUME:
0
CHG(%):
0.00		PREV:
3.820		LOW:
3.680		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Jul 263.6803.6803.6803.6800
29 Jul 263.8203.8203.8203.8200
28 Jul 263.8203.8203.8203.8200
27 Jul 263.7903.7903.7903.7900
23 Jul 263.7503.8103.7503.8100
22 Jul 263.9403.9403.9403.9401.0K
21 Jul 263.7903.7903.7903.7900
20 Jul 263.9203.9203.9203.9200
17 Jul 264.0804.1504.0804.1300
16 Jul 263.9204.0403.9204.0400

PROFILE

Name:Arbutus Biopharma Corp
About:Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 1 and phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:701 Veterans Circle, Warminster, PA, United States, 18974
Website:https://www.arbutusbio.com
ISIN:CA03879J1003

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:5.85 
Forward P/E:-5.41 
PEG Ratio:-0.01 
Price to Sales:4.41 
Price to Book:3.68 
Profit Margin:0.84 
Operating Margin:0.94 
Return on Assets:0.49 
Return on Equity:0.95 
Revenue:167.71M 
EBITDA:135.9M 
Shares:191.7M 
Market Cap:705.45M 

TECHNICAL INDICATORS

MA5:3.844.2%
MA10:3.906.1%
MA20:4.0810.9%
MA50:3.885.5%
MA100:3.823.7%
MA200:3.762.1%
STO9:8.33 
STO14:4.17 
RSI14:26.62 
WPR14:-95.83 
MTM14:-0.69
ROC14:-0.15 
ATR:0.11 
Week High:3.947.1%
Week Low:3.751.9%
Month High:4.5122.6%
Month Low:3.752.1%
Year High:4.5122.6%
Year Low:2.7633.2%
Volatility:9.00